Co-Diagnostics Price to Book Ratio

Co-Diagnostics (CODX) currently reports a P/B ratio of 0.16. That is below the Healthcare sector average of 6.9. Use the charts on this page to explore Co-Diagnostics's P/B ratio history and peer comparisons.

Co-Diagnostics's P/B ratio of 0.16 is lower than the Healthcare sector average of 6.9. That is roughly 97.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/B ratio is a valuation multiple that relates Co-Diagnostics's market price to a fundamental measure such as earnings, sales, or book value. At 0.16, CODX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/B ratio of 0.16, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 6.9. From there, open related valuation or income-statement pages for Co-Diagnostics, and consider following CODX for alerts when major investors trade the stock.

Co-Diagnostics is classified in the Healthcare sector. On P/B ratio, it currently shows 0.16 versus a sector average near 6.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CODX with unrelated industries.